Enfusion Inc (ENFN) stock saw a modest uptick, ending the day at $10.96 which represents a slight increase of $0.04 or 0.37% from the prior close of $10.92. The stock opened at $10.95 and touched a ...

NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered ...

NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between ...

Enfusion (NYSE:ENFN – Get Free Report)‘s stock had its “market perform” rating reaffirmed by equities research analysts at ...

Fintel reports that on January 13, 2025, William Blair downgraded their outlook for Enfusion (NYSE:ENFN) from Outperform to ...

Clearwater Analytics (NYSE:CWAN) has agreed to acquire Enfusion (NYSE:ENFN) for $11.25 a share, delivered in an approximately ...

NEW YORK & LONDON & HONG KONG, November 20, 2024--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced ...

Check the time stamp on this data. Updated AI-Generated Signals for Enfusion Inc. Class A (ENFN) available here: ENFN. Type a ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater ...

Morgan Stanley has recently resumed Enfusion Inc (ENFN) stock to Overweight rating, as announced on May 10, 2024, according to Finviz. Earlier, on February 28, 2024, Goldman had reduced the stock from ...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are ...